Bio-Rad LaboratoriesvsMerck & Company

BIO and MRK stock compared: price, dividend, valuation and results, from SEC filings.

BIO

Bio-Rad Laboratories, Inc.

$360.26

Value $9.8B

-1.67%
BIO's page

MRK

Merck & Company, Inc.

$144.46

Value $357B

-2.23%
MRK's page

Bio-Rad Laboratories (BIO) has a market value of $9.8B and Merck & Company (MRK) $357B. Over the last year, with dividends, BIO moved +15.0% and MRK +60.0%. The P/E is 9.6 for BIO and 145.6 for MRK. Dividend yield: BIO none, MRK 2.35%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    BIO$9.8B

    MRK$357B

    MRK is 36 times BIO

  • Revenue, 12 months

    BIO$2.6B

    MRK$67.4B

    MRK is 26 times BIO

  • Net income, 12 months

    BIO$1.0B

    MRK$2.5B

    MRK is 2.4 times BIO

  • Operating margin

    BIO-2.4%

    MRK–

  • ROIC

    BIO-0.6%

    MRK3.9%

    4.5 points apart

  • P/E

    BIO9.6

    MRK145.6

    MRK is 15 times BIO

  • Dividend yield

    BIO0.0%

    MRK2.4%

    2.4 points apart

  • 5-year return

    BIO-52.2%

    MRK+101.1%

    153.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

BIO-52.2%

MRK+101.1%

10020020222023202420252026
Returns by period
PeriodBIOWith dividendsMRKWith dividends
1 year since November 14, 2025+15.0%Price +15.0%+60.0%Price +55.5%
3 years since November 16, 2023+18.3%+5.8% a yearPrice +18.3%+55.2%+15.8% a yearPrice +41.6%
5 years since November 15, 2021-52.2%-13.7% a yearPrice -52.2%+101.1%+15.0% a yearPrice +72.6%
10 years since November 16, 2016+109.4%+7.7% a yearPrice +109.4%+228.0%+12.6% a yearPrice +141.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

BIOBio-Rad LaboratoriesMRKMerck & Company

Valuation

BIOMRK
Valuation
Price$360.26$144.46
Market value$9.8B$357B
Enterprise value (EV)$9.0B$401B
P/E9.6145.6
P/E, 5-year median–14.8
P/B1.38.0
EV/EBIT–84.3
Free cash flow yield3.4%4.1%

Results and growth

BIOMRK
Results and growth
Revenue, 12 months$2.6B$67.4B
Net income, 12 months$1.0B$2.5B
Free cash flow, 12 months$329M$14.7B
Earnings per share, 12 months$37.71$0.98
Revenue growth, year on year0.7%1.3%
Revenue growth a year, past+0.3%over 5 years+9.4%over 5 years
EPS growth a year, past-26.1%over 5 years+21.2%over 5 years

Margins and returns on capital

BIOMRK
Margins and returns on capital
Gross margin51.3%71.8%
Operating margin-2.4%–
Net margin39.5%3.6%
ROIC-0.6%3.9%
ROE14.3%5.2%

Balance sheet

BIOMRK
Balance sheet
Cash$1.7B$9.7B
Total debt$971M$53.8B
Net debt / EBITDA-8.25.7
Interest cover-1.3×2.4×

Dividends and buybacks

BIOMRK
Dividends and buybacks
Dividend yield–2.4%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield3.0%1.4%
Shareholder yield3.0%3.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: BIO or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Bio-Rad Laboratories or Merck & Company?

By market value, Merck & Company ($357B) is about 36.4 times Bio-Rad Laboratories ($9.8B), at today's prices.

How did BIO and MRK stock do over the last 10 years?

Since November 16, 2016, BIO's price moved +109.4% and MRK's +141.7%. With dividends: BIO +109.4% (+7.7% a year), MRK +228.0% (+12.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, BIO or MRK?

The dividend yield at today's price is none for Bio-Rad Laboratories and 2.35% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of BIO and MRK?

At today's price, the P/E is 9.6 for BIO and 145.6 for MRK. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Bio-Rad Laboratories or Merck & Company?

Over the last twelve months, the net margin was 39.5% for Bio-Rad Laboratories and 3.6% for Merck & Company, and the operating margin -2.4% and –. Revenue was $2.6B and $67.4B.

Which is the better investment, Bio-Rad Laboratories or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.